· Media Center
    · Main Page
    · Press Releases

    · Image Bank
    · Videos
    · Media Contacts


IQ Biometrix, Inc

PO Box 270323
Houston, TX 77277-0323



IQ Biometrix Appoints M. Riley Repko as Chairman of the Board of Directors

FREMONT, Calif., June 30, 2003 -- IQ Biometrix Inc. (OTCBB:IQBM), a worldwide provider of integrated law enforcement and security solutions, announced today the appointment of M. Riley Repko to the position of Chairman of the Board of Directors. Mr. Repko will take on key responsibilities including business model, government sales, and management and staff development.

“Riley Repko’s experience and track record speak for themselves; he will be an outstanding asset to the company,” said William Scigliano, CEO of IQ Biometrix. “We’re entering an exciting growth phase, moving from product development and patent issuances to major alliances and acquisitions and penetration into corporate and government markets. It is the strength of this momentum that is attracting corporate leaders such as Riley.”

Mr. Repko has two decades of direct sales and business development expertise, all with aggressive growth technology companies, with a focus on the Public Sector and Asia-Pacific market strategies. He has held senior positions at TRW Systems Inc. and Siebel Systems Inc. He started and directed Oracle Corporation’s Government & Corporate Affairs office and Managed Air Force Programs for Litton Systems, Inc.

His corporate experience is complimented by an international upbringing and 24 years of commissioned service in the U.S. Air Force, 19 as a Reservist. He is currently the Mobilization Assistant to the Commander, Space Warfare Center of the Air Force Space Command, and has also served in a similar capacity to the AF Space Command’s CIO and Director of Communications & Information. Mr. Repko remains active with several professional and information technology industry associations.

Mr. Repko’s academic credentials include attending the Senior Military School at the National Defense University; a MS from the U.S. Air Force’s Air War College; an MBA (summa cum laude) from St. Mary’s University (TX) in Operations Management; a BS in Electrical Engineering from the Air Force Institute of Technology (OH); and a BS in Physics/Math (cum laude) from St. Bonaventure University (NY).

In announcing Riley Repko’s appointment, Mr. Scigliano confirmed that Morden Lazarus will remain on the IQB board to continue to direct the corporation’s drive into the private security arena.

About IQ Biometrix, Inc.
IQ Biometrix, Inc. (IQBM) provides law enforcement and security technology solutions for government and private industry. IQ Biometrix, an innovative California-based company is a leading provider of facial composite technology for law enforcement agencies in North America. FACES is currently used by thousands of policing agencies worldwide, including the Central Intelligence Agency and the Federal Bureau of Investigation. IQB is currently developing new applications based on this foundation technology tailored to meet the needs of national, business and personal security. Its solutions practice is focused on integrating IQB and partner technologies to provide customized responses to client needs. Further information about IQB can be found at www.iqbiometrix.com.

Safe Harbor Statement
To the extent that any of the statements contained herein are forward-looking, such statements are based on current expectations that involve a number of uncertainties and risks. Such uncertainties and risks include, but are not limited to, growth in the NAS market, market acceptance of products, the development of new products, the enhancement of existing products, manufacturing delays, dependence on principal customers, competitive pricing pressures, product volume and mix, global economic conditions, dependence on international operations, availability of key components, timing of orders received, and introduction of competitor products having technological and/or pricing advantages. As a result, the Company's operating results may fluctuate, especially when measured on a quarterly basis. Actual results may differ materially from such expectations. Investors are directed to consider other risks and uncertainties in documents, including forms 8K and 10QSB, filed by the company with the Securities and Exchange Commission, www.sec.gov.

Contact Information:
Liviakis Financial Communications
John Liviakis, 415/389-4670



Back to Press Releases

Copyright © 2003 IQ Biometrix - All rights reserved.